| Literature DB >> 24482137 |
Yan-Hui Gao1, Hao-Peng Zhang2, Shu-Meng Yang3, Yue Yang4, Yu-Yan Ma4, Xin-Yu Zhang2, Yan-Mei Yang4.
Abstract
Arsenic trioxide (As2O3) has been recognized as a potential chemotherapeutic agent, yet the details concerning its mechanism of action in solid cancers remain undetermined. The present study assessed the role of Akt in the cell death induced by As2O3. The MTT assay showed that As2O3 suppressed the proliferation of SGC-7901 cells in a dose- and time-dependent manner. Characteristic apoptotic changes were observed in the As2O3‑treated cells by Hoechst 33342 staining, and FACS analysis showed that As2O3 caused dose-dependent apoptotic cell death. As2O3 activated caspase-3 and -9, and PARP cleavage in a dose-dependent manner. Compromised mitochondrial membrane potential and an increased protein level of Bax indicated involvement of mitochondia. As2O3 decreased the levels of p-Akt (Ser473), p-Akt (Thr308) and p-GSK-3β (Ser9), suggesting that As2O3 inactivated Akt kinase. In addition, LY294002 (a PI3 kinase inhibitor) augmented the apoptosis induced by As2O3. These results demonstrated that inhibition of PI3K/Akt signaling was involved in As2O3-induced apoptosis of gastric cancer SGC-7901 cells.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24482137 DOI: 10.3892/or.2014.2994
Source DB: PubMed Journal: Oncol Rep ISSN: 1021-335X Impact factor: 3.906